A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy

• Stephanie Ströbele,

  Affiliations Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany, Department of Neurosurgery, University Medical Center Ulm, Ulm, Germany

  ⨯
• Matthias Schneider,

  Affiliations Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany, Department of Neurosurgery, University Medical Center Ulm, Ulm, Germany

  ⨯
• Lukas Schneele,

  Affiliation Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany

  ⨯
• Markus D. Siegelin,

  Affiliation Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, United States of America

  ⨯
• Lisa Nonnenmacher,

  Affiliation Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany

  ⨯
• Shaoxia Zhou,

  Affiliation Department of Clinical Chemistry, University Medical Center Ulm, Ulm, Germany

  ⨯
• Georg Karpel-Massle,

  Affiliations Department of Neurosurgery, University Medical Center Ulm, Ulm, Germany, Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, United States of America

  ⨯
• Mike-Andrew Westhoff ,

  * E-mail: andrew.westhoff@uniklinik-ulm.de

  ¶‡ These authors have shared seniority on this work.

  Affiliation Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany

  ⨯
• Marc-Eric Halatsch ,

  ¶‡ These authors have shared seniority on this work.

  Affiliation Department of Neurosurgery, University Medical Center Ulm, Ulm, Germany

  ⨯
• Klaus-Michael Debatin

  ¶‡ These authors have shared seniority on this work.

  Affiliation Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany

  ⨯